Wagner DC - Search Results

1

Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.

Gerber TS, Bartsch F, Wagner DC, Schindeldecker M, Heuft LK, Roth W, Lang H, Straub BK. Gerber TS, et al. Among authors: wagner dc. J Clin Med. 2021 Jun 22;10(13):2745. doi: 10.3390/jcm10132745. J Clin Med. 2021. PMID: 34206469 Free PMC article.

2

Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer.

Martin SZ, Wagner DC, Hörner N, Horst D, Lang H, Tagscherer KE, Roth W. Martin SZ, et al. Among authors: wagner dc. BMC Cancer. 2019 Nov 1;19(1):1030. doi: 10.1186/s12885-019-6270-4. BMC Cancer. 2019. PMID: 31675944 Free PMC article.

3

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.

Woerl AC, Eckstein M, Geiger J, Wagner DC, Daher T, Stenzel P, Fernandez A, Hartmann A, Wand M, Roth W, Foersch S. Woerl AC, et al. Among authors: wagner dc. Eur Urol. 2020 Aug;78(2):256-264. doi: 10.1016/j.eururo.2020.04.023. Epub 2020 Apr 27. Eur Urol. 2020. PMID: 32354610

4

Different dissolution media lead to different crystal structures of talinolol with impact on its dissolution and solubility.

Wagner D, Glube N, Berntsen N, Tremel W, Langguth P. Wagner D, et al. Drug Dev Ind Pharm. 2003 Sep;29(8):891-902. doi: 10.1081/ddc-120024185. Drug Dev Ind Pharm. 2003. PMID: 14570310

5

Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.

Tubic M, Wagner D, Spahn-Langguth H, Weiler C, Wanitschke R, Böcher WO, Langguth P. Tubic M, et al. Eur J Pharm Sci. 2006 Nov;29(3-4):231-9. doi: 10.1016/j.ejps.2006.04.005. Epub 2006 Apr 26. Eur J Pharm Sci. 2006. PMID: 16713700

6

Intestinal drug efflux: formulation and food effects.

Wagner D, Spahn-Langguth H, Hanafy A, Koggel A, Langguth P. Wagner D, et al. Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S13-31. doi: 10.1016/s0169-409x(01)00183-1. Adv Drug Deliv Rev. 2001. PMID: 11576693 Review.

7

In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect.

Tubic M, Wagner D, Spahn-Langguth H, Bolger MB, Langguth P. Tubic M, et al. Pharm Res. 2006 Aug;23(8):1712-20. doi: 10.1007/s11095-006-9020-7. Pharm Res. 2006. PMID: 16832615

8

Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial).

Fottner C, Apostolidis L, Krug S, Rinke A, Grün B, Michl P, Gress TM, Wagner DC, Roth W, Mettler E, Topsch J, Ruckes C, Galle PR, Weber MM. Fottner C, et al. Among authors: wagner dc. Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-2461. Online ahead of print. Clin Cancer Res. 2024. PMID: 39786465

9

Periodic Bleeding from a Cesarean Section Scar Fistula.

Klamminger GG, Wagner DC, Beeres M, Hasenburg A, Schwab R. Klamminger GG, et al. Among authors: wagner dc. Diagnostics (Basel). 2024 Oct 29;14(21):2403. doi: 10.3390/diagnostics14212403. Diagnostics (Basel). 2024. PMID: 39518371 Free PMC article.

10

PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays.

Klempner SJ, Cowden ES, Cytryn SL, Fassan M, Kawakami H, Shimada H, Tang LH, Wagner DC, Yatabe Y, Savchenko A, Salcius J, Johng D, Chen J, Montenegro G, Moehler M. Klempner SJ, et al. Among authors: wagner dc. JCO Precis Oncol. 2024 Jun;8:e2400230. doi: 10.1200/PO.24.00230. JCO Precis Oncol. 2024. PMID: 38822761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters